Rui Lyu

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin 300020
Tianjin, 301600, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma

Clinical analysis of bendamustine combined with rituximab as first-line therapy for B-cell lymphoproliferative disorders other than follicular lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 07, 2026

Familial hemophagocytic lymphohistiocytosis presenting initially as autoimmune lymphoproliferative syndrome: a case report

Familial hemophagocytic lymphohistiocytosis presenting initially as autoimmune lymphoproliferative syndrome: a case report

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: July 06, 2026

Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China.

Ibrutinib alternating with three cycles of interval fludarabine, cyclophosphamide, and rituximab (FCR) in adults with untreated chronic lymphocytic leukaemia as time-limited regimen: a single-arm, multicentre phase 2 trial in China.

Journal: EClinicalMedicine

Published: August 15, 2025

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Obinutuzumab plus bendamustine as first-line therapy for indolent B-cell lymphomas: a prospective multicenter open-label study.

Journal: MedScience

Published: August 06, 2025

Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma.

Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphoma.

Journal: Chinese medical journal

Published: May 06, 2025

An unconventional topology of betacoronavirus membrane protein drives viral assembly.

An unconventional topology of betacoronavirus membrane protein drives viral assembly.

Journal: Science bulletin

Published: February 28, 2025

Clinical characteristics and prognosis analysis in patients with bone marrow invasive follicular lymphoma

Clinical characteristics and prognosis analysis in patients with bone marrow invasive follicular lymphoma

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: January 07, 2025

The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma.

The optimal time and clinical implications of measurable residual disease detection in mantle cell lymphoma.

Journal: Annals of hematology

Published: October 28, 2024

Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study.

Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 28, 2024

The efficacy and safety of ibrutinib in the treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia

The efficacy and safety of ibrutinib in the treatment of lymphoplasmacytic lymphoma/Waldenström macroglobulinemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: September 22, 2024

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Thalidomide-based regimen shows promising efficacy in large granular lymphocytic leukemia: a multicenter phase II study.

Journal: Signal transduction and targeted therapy

Published: August 28, 2024

γδ and αβ T-cell large granular lymphocytic leukaemia have similar characteristics and outcomes.

γδ and αβ T-cell large granular lymphocytic leukaemia have similar characteristics and outcomes.

Journal: British journal of haematology

Published: August 16, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026